Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel salinomycin derivatives via click chemistry offer enhanced antitumor activity. Reliable supplier for pharmaceutical intermediates with scalable synthesis routes.
Patent CN115340572B discloses X-Binaphane, a novel xanthene-based bisphosphine ligand enabling high stereoselectivity in API manufacturing with scalable synthesis.
Patent CN106008195B reveals a green iodination method for Elvitegravir intermediates, offering high purity and scalable manufacturing for reliable supply chains.
Novel hydrothermal route for noble metal complexes offers high purity and potential anti-tumor applications for pharmaceutical intermediates and research.
Patent CN108586283B reveals a green visible-light method using Rose Bengal, eliminating metal oxidants for safer pharmaceutical intermediate manufacturing.
Novel patent CN113929686B offers high-purity ibutenib manufacturing with cost reduction and supply chain reliability for pharma intermediates.
Novel rearrangement route for Palbociclib ensures high purity and scalable production for pharmaceutical supply chains globally.
Patent CN103113441A details a cost-effective Capecitabine synthesis using silylation and glycosylation, offering significant supply chain advantages for API manufacturers.
Novel patent CN110606842A offers high-yield heavy-metal-free synthesis for pharmaceutical intermediates ensuring supply chain stability.
Advanced process for high-purity ondansetron synthesis reducing exo-methylene impurities. Cost-effective manufacturing solution for pharmaceutical supply chains.
Novel patent CN105037394A enables high-purity Latamoxef Sodium production. Achieve ICH Q3A compliance with reduced steps and enhanced supply chain reliability for global buyers.
Patent CN112708641A discloses a high-efficiency chemo-enzymatic route for tomoxetine. Achieves >99.9% ee and high substrate loading for cost-effective manufacturing.
Patent CN1742002A discloses novel piperazine intermediates for Levocetirizine. Discover high-purity synthesis routes offering significant cost reduction and supply reliability.
Patent CN112707867B discloses a high-yield route for anticancer intermediates, offering cost reduction in API manufacturing and reliable supply chain solutions.
Advanced synthesis of Schiff base intermediates via patent CN103880706A. Delivers high purity, cost-effective manufacturing, and reliable supply chain solutions for global pharmaceutical partners.
Patent CN119431386A reveals photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable green chemistry processes.
Novel CN114853764B patent process enhances ibutenib synthesis safety and purity. Delivers significant cost reduction and supply chain reliability for global API intermediate manufacturing partners.
Novel synthesis route for Efavirenz chiral ligand from L-Alanine. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel phosphate-modified catalyst enables high-yield production of HIV drug intermediate with improved optical purity and scalable fixed-bed process technology for global supply chains.
Patent CN110041377B details a novel synthetic method for O-mannan core structures M1, M2, and M3, offering high regioselectivity and scalable production for pharmaceutical intermediates.